D'Cunha, NM and Peterson, GM and Baby, KE and Thomas, J, Impetigo: A need for new therapies in a world of increasing antimicrobial resistance, Journal of Clinical Pharmacy and Therapeutics pp. 1-4. ISSN 1365-2710 (2017) [Contribution to Refereed Journal]
© 2017 John Wiley & Sons Ltd
What is known and objective: Impetigo is a highly contagious bacterial skin infection and is one of the most common skin infections in children. Antibiotics are the first-line treatment when multiple lesions exist, but with an increasing prevalence of antibioticresistant bacteria the successful management of impetigo in the future is an area of concern.
Comment: Current treatment options that favour the use of oral antibiotic therapy are increasingly problematic. Widespread use of these agents contributes to antimicrobial resistance and has adverse consequences for individuals and communities. There is a need for new topical antimicrobials and antiseptics as an alternative treatment strategy.
What is new and conclusion: To successfully treat impetigo into the future and ensure that therapy does not contribute to bacterial resistance, additional research is required to ascertain the usefulness of alternative agents, including new topical antimicrobials and antiseptics.
|Item Type:||Contribution to Refereed Journal|
|Keywords:||Impetigo antibiotics management clinical|
|Research Division:||Biomedical and Clinical Sciences|
|Research Group:||Pharmacology and pharmaceutical sciences|
|Research Field:||Clinical pharmacology and therapeutics|
|Objective Group:||Clinical health|
|Objective Field:||Clinical health not elsewhere classified|
|UTAS Author:||Peterson, GM (Professor Gregory Peterson)|
|Web of Science® Times Cited:||14|
Repository Staff Only: item control page